The University of Chicago Header Logo

Connection

Mark Talamonti to Patient Selection

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Patient Selection.
Mark Talamonti
Connection Strength
0.272
Patient Selection
  1. Borderline resectable pancreatic cancer: a new classification for an old challenge. Ann Surg Oncol. 2006 Aug; 13(8):1019-20.
    View in: PubMed
    Score: 0.207
  2. Local-regional therapy for metastatic liver tumors. Cancer Treat Res. 1998; 98:172-99.
    View in: PubMed
    Score: 0.029
  3. Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Ann Surg. 2014 Aug; 260(2):372-7.
    View in: PubMed
    Score: 0.023
  4. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients. J Gastrointest Surg. 2007 Nov; 11(11):1460-7; discussion 1467-9.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.